Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|11|1|114-127

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.11, Iss.1, 2013-01, pp. : 114-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-Resistant Epilepsy and Surgery

By  

Current Neuropharmacology, Vol. 16, Iss. 1, 2017-12 ,pp. : 17-28

Bentham Science Publishers

Access to resources Recommend Favorite

Could Hippocampal Neurogenesis be a Future Drug Target for Treating Temporal Lobe Epilepsy?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 5, 2007-10 ,pp. : 342-357

Bentham Science Publishers

Access to resources Recommend Favorite

TRPV1 Channel: A Potential Drug Target for Treating Epilepsy

By  

Current Neuropharmacology, Vol. 13, Iss. 2, 2015-03 ,pp. : 239-247

Bentham Science Publishers

Access to resources Recommend Favorite

Ensure a comprehensive approach when treating drug-resistant tuberculosis

By  

Drugs & Therapy Perspectives, Vol. 28, Iss. 3, 2012-03 ,pp. : 15-18

Adis International

Access to resources Recommend Favorite

Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches

By Potschka Heidrun  

Pharmacogenomics, Vol. 11, Iss. 10, 2010-10 ,pp. : 1427-1438

Future Medicine

Access to resources Recommend Favorite